10x Genomics, Inc.

TXG

Precision medicineBiotech & pharmaceuticalsGenomic analysis

$64.23vs prev close▼-0.89(-1.37%)

$11.1652W Range$65.47

98% from low

+16.08 (+34.75%)Past 1M

Price

ARK Trade PatternPREMIUM

1M Trades

16 sells

Consecutive sells

1M net buy

-$60.6M

≈ -1.1M shares

Portfolio Weight

2.57%

1M +0.16%p

Holding ETFs

2 ETFs

ARKG · ARKK

Price Effect (Sell)

Shares decreased, but price appreciation increased portfolio weight.

Shares -19.0% · Market value -3.9% · Weight +0.16%p

Trade Intensity

Consecutive sells 16

Basis: 16 sells · 0 buys in 1M · Multi-ETF simultaneous sell · weight +0.16%p increase

Trade Log16-day SELL streak

Date	Action	ETF	Shares	Close	Est. total
26.08.21	SELL	ARKK	10,033	$65.12	$653.3K
26.08.20	SELL	ARKK	65,922	$63.87	$4.2M
26.08.19	SELL	ARKG · ARKK	203,242	$62.19	$12.6M
26.08.18	SELL	ARKG · ARKK	36,478	$55.63	$2.0M
26.08.17	SELL	ARKG · ARKK	94,968	$57.99	$5.5M
26.08.14	SELL	ARKG · ARKK	10,951	$56.09	$614.2K
26.08.13	SELL	ARKG · ARKK	51,171	$58.15	$3.0M
26.08.12	SELL	ARKG · ARKK	23,174	$57.75	$1.3M
26.08.11	SELL	ARKK	19,972	$58.48	$1.2M
26.08.10	SELL	ARKG · ARKK	122,590	$58.57	$7.2M
26.08.04	SELL	ARKK	24,454	$47.86	$1.2M
26.08.03	SELL	ARKK	251,094	$47.01	$11.8M
26.07.31	SELL	ARKK	77,047	$47.27	$3.6M
26.07.29	SELL	ARKK	23,953	$46.32	$1.1M
26.07.28	SELL	ARKK	25,096	$47.05	$1.2M

08.21SELL

10,033

ARKKClose$65.12Est. total$653.3K

08.20SELL

65,922

ARKKClose$63.87Est. total$4.2M

08.19SELL

203,242

ARKG · ARKKClose$62.19Est. total$12.6M

08.18SELL

36,478

ARKG · ARKKClose$55.63Est. total$2.0M

08.17SELL

94,968

ARKG · ARKKClose$57.99Est. total$5.5M

08.14SELL

10,951

ARKG · ARKKClose$56.09Est. total$614.2K

08.13SELL

51,171

ARKG · ARKKClose$58.15Est. total$3.0M

08.12SELL

23,174

ARKG · ARKKClose$57.75Est. total$1.3M

08.11SELL

19,972

ARKKClose$58.48Est. total$1.2M

08.10SELL

122,590

ARKG · ARKKClose$58.57Est. total$7.2M

08.04SELL

24,454

ARKKClose$47.86Est. total$1.2M

08.03SELL

251,094

ARKKClose$47.01Est. total$11.8M

07.31SELL

77,047

ARKKClose$47.27Est. total$3.6M

07.29SELL

23,953

ARKKClose$46.32Est. total$1.1M

07.28SELL

25,096

ARKKClose$47.05Est. total$1.2M

1 / 14

Prices estimated from market closing prices on trade dates. Actual execution prices may differ. This is not investment advice.

Stock Timeline

Institutional Holders

2 Holding · 0 Sold · Q4 2025

Based on ARK ETF real-time + 13F quarterly filings

Cathie WoodARK Invest

LIVE

6,695,116

Portfolio Weight

2.57%

in ETF 8.83%

Est. Value

$318M

30D Net

-$101M

Ray DalioBridgewater Associates

New Buy

177,734

Portfolio Weight

0.01%

Est. Value

$3M

Change

New position

13F data may be delayed up to 90 days.

Market Context

Analyst Consensus

※ Analyst opinions are for reference only and do not constitute investment advice. Each securities firm may have different opinions.

Overall Opinion

Buy

Strong Buy

Buy

Hold

Analyst Targets

avg.

$49.54

vs Current ▼ -11.0% downside

Current$55.63

Low ~ High$40.00 ~ $65.00

Firm

Position

Price Target

Upside / Downside

Close Price

Action

Date

Stephens & Co.

Overweight

$65.00

+16.84%

—

Maintain

2026-08-12

Piper Sandler

Neutral

$47.00

-15.51%

—

Maintain

2026-08-10

Canaccord Genuity

Buy

$60.00

+7.86%

—

Maintain

2026-08-10

Citigroup

Neutral

$50.00

-10.12%

—

Maintain

2026-08-07

Morgan Stanley

Equal-Weight

$40.00

-28.10%

—

Maintain

2026-08-07

1 / 4

Avg Target

$49.54

vs Current ▼ -11.0% downside

Buy

16 analysts

Strong Buy 1Buy 5Hold 10

Low $40.00

Current $55.63

High $65.00

Firm	Position	Target	Upside	Close	Action	Date
Stephens & Co.	Overweight	$65.00	+16.84%	—	Maintain	26.08.12
Piper Sandler	Neutral	$47.00	-15.51%	—	Maintain	26.08.10
Canaccord Genuity	Buy	$60.00	+7.86%	—	Maintain	26.08.10
Citigroup	Neutral	$50.00	-10.12%	—	Maintain	26.08.07
Morgan Stanley	Equal-Weight	$40.00	-28.10%	—	Maintain	26.08.07

1 / 4

Price Information

Previous Close$65.12

Open$64.39

Day Range$61.75 - $65.47

52-Week Range$11.16 - $65.47

1-Year Change362.83%

Trading Volume

Volume3,138,241

Avg Volume (3mo)3,248,804

Valuation

Market Cap8.5B

Book Value$6.31

Shares Outstanding120,212,296

Financials

Revenue (TTM)616.9M

Net Income-75,125,000

EPS$-0.59

EBITDA-41,201,000

Profitability

P/E Ratio-

P/B Ratio10.32

Return on Equity (ROE)-9.40%

Return on Assets (ROA)-5.05%

Profit Margin-12.18%

EV/EBITDA-194.44

Beta2.04

Dividend

Dividend Rate-

Dividend Yield-

Technical

RSI(14)77.35

Company Overview

10x Genomics is a life science technology company that provides instruments, consumables, and software for analyzing biological systems. Their main products include the Chromium platform for single-cell analysis and the Visium and Xenium platforms for spatial analysis of genes and proteins within tissues. They serve a global market of academic, government, and industry research institutions.

P/B

10.32

High valuation

ROE

-9.4%

Net loss

Beta

2.04

Extreme volatility

RSI(14)

77.3

Overbought

AI-generated summary. Not investment advice.

10x Genomics, Inc.

Analyst Consensus

Price Information

Trading Volume

Valuation

Financials

Profitability

Dividend

Technical

Related ARK stocks